FTI Consulting Appointed Senior Managing Director
Christina Morris joins the firm's healthcare practice to lead technology-enabled business transformations.
Updated on Oct. 1, 2026 in People
Live Poll
Do you trust that large corporations can successfully implement artificial intelligence without compromising operational stability?
FTI Consulting has appointed Christina Morris as a Senior Managing Director within its Healthcare Risk Management and Advisory practice. Based in Washington, D.C., Morris will guide pharmaceutical and life sciences organizations through technology-led operational overhauls.
Why it matters
The appointment reflects growing industry pressure on healthcare organizations to modernize business processes while simultaneously navigating strict regulatory compliance and rising operational costs.
FTI Consulting reported $3.8 billion in revenue for fiscal year 2025 and maintained a workforce of 8,100 people as of June 30, 2026. Morris joins the firm with over 25 years of professional experience.
The players
Christina Morris
A Senior Managing Director with over 25 years of experience specializing in technology-enabled business transformation for healthcare and life sciences organizations.
FTI Consulting
A global advisory firm with operations in 32 countries that provides performance improvement, risk management, and restructuring services to large-scale enterprises.
The details
Morris will oversee initiatives focused on modernizing operating models for life sciences clients. Her work centers on implementing automation, artificial intelligence, and data analytics to optimize core business management. These strategies aim to balance necessary performance improvements against the increasingly rigorous regulatory environment facing the pharmaceutical sector.
Timeline
June 30, 2026: FTI Consulting staff reached over 8,100 employees.
Fiscal year 2025: FTI Consulting recorded $3.8 billion in total revenue.
October 1, 2026: FTI Consulting announced the appointment of Christina Morris.
Market Landscape
This appointment aligns with the broader industry trend of life sciences firms prioritizing digital transformation to manage regulatory and cost pressures. It follows a pattern of global consultancies scaling technical advisory leadership to navigate complex compliance requirements.
Operators in the healthcare and life sciences sectors should monitor how these modernization initiatives translate into efficiency gains and cost structures. Reviewing your internal automation capabilities against current industry benchmarking may be necessary to maintain competitive parity.
The takeaway
The move underscores that digital integration is now a fundamental requirement for navigating healthcare's regulatory and financial complexities. Operators should track how competitors in their segment utilize similar data-driven models to optimize back-office operations.
Further reading
For more on shifts in industry leadership, visit our People section.
Live Poll
Do you trust that large corporations can successfully implement artificial intelligence without compromising operational stability?
